Rlip depletion suppresses growth of breast cancer

Chhanda Bose, Sushma Yadav, Sharad S. Singhal, Jyotsana Singhal, Ashly Hindle, Jihyun Lee, Naga K.S. Cheedella, Shabnam Rehman, Rakhshanda Layeequr Rahman, Catherine Jones, Meenakshi Darden, Philip T. Palade, David Berz, Sharda P. Singh, Sanjay Awasthi

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

RLIP76 (RAL-binding protein-1, Rlip) is a stress-protective mercapturic-acid-pathway transporter protein that also plays a key role in regulating clathrin-dependent endocytosis as a Ral effector. Targeted inhibition or depletion of Rlip causes regression of xenografts of many cancers and is capable of abrogating tumor formation in p53-null mice. This is associated with the reversion of the abnormal methylomic profile of p53-null mice to wild-type. In a query of The Cancer Genome Atlas (TCGA) databases, we found that Rlip expression was associated with poor survival and with significant differences in the frequencies of PIK3CA mutation, MYC amplification, and CDKN2A/B deletion, which were the most commonly mutated, amplified, and deleted genes, respectively, among TCGA breast cancer patients. We conducted the present study to further examine the effects of Rlip inhibition and to evaluate the in vitro and in vivo efficacy in breast cancer. Using immunogold electron microscopy, we found that plasma-membrane Rlip was accessible to cell-surface antibodies in the MCF7 (ER+) breast cancer cell line. Rlip depletion resulted in decreased survival of MCF7 and MDA-MB-231 cells and increased terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positivity and DNA laddering, indicating apoptotic cell death. Additionally, in vitro knockdown of Rlip inhibited EGF endocytosis and WNT/MAPK signaling. Xenograft studies in nude mice showed regression of breast cancer via antisense-mediated depletion of Rlip mRNA as well as by anti-Rlip antibody. Finally, knockdown of Rlip by antisense locked nucleic acid oligonucleotides increased markers for apoptotic signaling and decreased markers for proliferation, angiogenesis, and cell cycling in MCF7 and MDA-MB-231luc xenografts. Our findings validate Rlip as an attractive target in breast cancer.

Original languageEnglish (US)
Article number1446
JournalCancers
Volume12
Issue number6
DOIs
StatePublished - Jun 2020
Externally publishedYes

Keywords

  • Apoptosis
  • Breast cancer
  • Endocytosis
  • RalBP1
  • Rlip76

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Rlip depletion suppresses growth of breast cancer'. Together they form a unique fingerprint.

Cite this